Recursion Pharmaceuticals, Inc. (RXRX)

3.825 +0.22 (+6.25%) USD  |  NASDAQ  |  Apr 17, 11:57
More

Recursion Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Quince Therapeutics, Inc. Upgrade